Pcsa stock.

Open 2.1100. Bid 2.0500 x 100. Ask 2.1100 x 200. Day's Range 2.0813 - 2.1900. 52 Week Range 1.4000 - 18.0000. Volume 56,712. Avg. Volume 1,484,388. Market Cap (intraday) 5.973M. Beta (5Y Monthly)...Processa Pharmaceuticals (PCSA) stock price prediction is 0.38653520466552 USD. The Processa Pharmaceuticals stock forecast is 0.38653520466552 USD for 2025 ...Jan 26, 2024 ... (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ... shares of common stock (or pre-funded warrants in lieu thereof) and ...4 days ago · Processa Pharma (NASDAQ: PCSA) just reported results for the first quarter of 2024. Processa Pharma reported earnings per share of -$1.11. The company did not report any revenue for the quarter ...

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) is a clinical-stage pharmaceutical company focusing on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for cancer patients. CEO George Ng recently issued a letter to shareholders, emphasizing the company's pivot to focus on oncology drug …

View the latest Processa Pharmaceuticals Inc. (PCSA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Processa Pharmaceuticals (PCSA) shed ~10% for the fourth straight session on Friday after announcing plans to issue more than $6M of its common stock. Read the full story here.Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304. PCS Share Price: Find the latest news on PCS Stock Price. Get all the information on PCS with historic price charts for NSE / BSE. Experts & Broker view also get the PCS Ltd. buy/sell tips ...

Unit convert

PCSA Nasdaq Stock Market. PCSA Nasdaq Stock Market. PCSA Nasdaq Stock Market. Market closed Market closed. No trades. See on Supercharts. Overview Financials . News . Ideas Technicals Forecast . PCSA news. Time Symbol Headline Provider. Love in every #TradingView. 60M+ Traders and investors use our platform. #1. Top website in the …

With Processa Pharmaceuticals stock trading at $2.22 per share, the total value of Processa Pharmaceuticals stock (market capitalization) is $6.34M. Processa Pharmaceuticals stock was originally listed at a price of $2,058.00 in Nov 21, 2013. If you had invested in Processa Pharmaceuticals stock at $2,058.00, your return over the last 10 years ...View Processa Pharmaceuticals, Inc. PCSA stock quote prices, financial information, real-time forecasts, and company news from CNN.Bluberries. Pharmaceutical company Processa Pharmaceuticals (NASDAQ:PCSA) said on Thursday that it is set to effect a 1-for-20 reverse stock split to regain compliance with Nasdaq rule.The share ...Processa Pharmaceuticals Inc stock (PCSA) in USD. 1 PCSA = 2.91 USD. 1 maand. 6 maanden. 1 year. 5 jaar. Processa Pharmaceuticals Inc stock performance at a glance. Check Processa Pharmaceuticals Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. PCSA Stock …PCSA is a biopharmaceutical company developing drugs for fibrotic diseases. It has a low price, a high uncertainty rating, and no analyst coverage. See its …

Processa Pharmaceuticals (PCSA) shed ~10% for the fourth straight session on Friday after announcing plans to issue more than $6M of its common stock. Read the full story here.In today’s fast-paced business world, effective stock management is crucial for any company that deals with software products. Software stock management refers to the process of ov...Apr 25, 2024 ... The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.25 A.M. ET). In the Green. PCSA Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Processa Pharmaceuticals, Inc. PCSA stock quote prices, financial information, real-time forecasts, and company news ... Stock Price Forecast. The 2 analysts with 12-month price forecasts for PCSA stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 187.08% from the current stock price of 2.09. According to 3 analysts, the average rating for PCSA stock is "Buy." The 12-month stock price forecast is $6.0, which is an increase of 170.27% from the latest price. Processa Pharmaceuticals Inc stock price live, this page displays NASDAQ PCSA stock exchange data. View the PCSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Processa Pharmaceuticals Inc real time stock price chart below.

Bluberries. Pharmaceutical company Processa Pharmaceuticals (NASDAQ:PCSA) said on Thursday that it is set to effect a 1-for-20 reverse stock split to regain compliance with Nasdaq rule.The share ...

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...Insiders have been net buyers of 5.4% shares of the company over the past six months. However, the stock is seeing signs of weakness, as it is currently trading below its 50-day and 200-day moving averages of $0.61 and $1.84, respectively. This article provides insight into the metrics that are reflective of the current challenges the company ...Discover historical prices for PCSA stock on Yahoo Finance. View daily, weekly or monthly format back to when Processa Pharmaceuticals, Inc. stock was issued.... PCSA Market Cap against competitors ... stock's last observed trading price. In the case of ... Stock ScreenerStock IdeasMetrics ExplorerChart EditorWatchlists ...Processa Pharmaceuticals Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology …Oct 25, 2016 · Find the latest PCS, PCS stock market data. Get a full understanding of how PCS is performing with stock quotes and prices, as well as real-time news and analysis. Get the latest stock price, quote, news and history of PCSA, a biotechnology company developing drugs for neurodegenerative diseases. See key data, market cap, data sources and more on Nasdaq.Receive PCSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCSA) was last updated on 4/26/2024 by MarketBeat.com StaffJan 26, 2024 ... (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ... shares of common stock (or pre-funded warrants in lieu thereof) and ... PCSA-1.2 is a circuit board holder. The ESD safe circuit board holder of the ideal tool for fitting circuit boards with components. The holder can easily be remounted in single parts and be reassembled in different combinations. It is an ESD soft foam, consisting of two layers. It is suitable to PCSA-1 and PCSA-1N models.

Topps corporation

View Processa Pharmaceuticals, Inc. PCSA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Interactive Chart for Processa Pharmaceuticals, Inc. (PCSA), analyze all the data with a huge range of indicators.Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Find the latest news headlines from Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com. Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, has announced a 1-for-20 reverse stock split.The reverse split was initially approved by shareholders in …Whether you're a Wall Street veteran or an amateur investor who's just starting out, it's only natural that you'll want to keep an eye on the value of your stocks and shares. If yo...Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... PCSA. Trailing total returns as ...PCSA stock is up about 90% as of this writing, although shares climbed more than 150% at one point today. Undergirding sentiment are encouraging safety results regarding Processa’s anti-cancer ... PCSA Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Processa Pharmaceuticals, Inc. PCSA stock quote prices, financial information, real-time forecasts, and company news ... View the real-time Processa Pharmaceuticals Inc (NASDAQ PCSA) share price. Assess historical data, charts, technical analysis and contribute in the forum.5.8400. 5.2000. 5.2400. 5.2400. 2,125. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for PCSA stock on Yahoo Finance. View daily, weekly or monthly formats back to when Processa Pharmaceuticals, Inc. stock was issued.Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules. (GlobeNewswire) Jan-04-23 08:30AM. Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.Interactive Chart for Processa Pharmaceuticals, Inc. (PCSA), analyze all the data with a huge range of indicators.

3.1900. 3.2900. 3.2900. 23,200. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for PCSA stock on Yahoo Finance. View daily, weekly or monthly formats back to when Processa Pharmaceuticals, Inc. stock was issued.Find the latest news headlines from Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com.The latest Processa Pharmaceuticals stock prices, stock quotes, news, and PCSA history to help you invest and trade smarter. ... Processa Pharmaceuticals Stock Snapshot. 2.31 Bid. 100.00 Bid Size ... Complete Processa Pharmaceuticals Inc. stock information by Barron's. View real-time PCSA stock price and news, along with industry-best analysis. Instagram:https://instagram. hulu lohin Processa Pharmaceuticals Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology and other high unmet medical need diseases with unparalleled regulatory science and clinical expertise. Our drug candidates are intended for patients who have limited ... May 9, 2024 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Processa Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for PCSA. The average twelve-month price prediction for Processa Pharmaceuticals is $8.00 with a high price target of $8.00 and a low price target of $8.00. flight to barcelona spain A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. fitbit support line Bench Vices, PCB Holders, Clamps ▻ PCSA-2N from ideal-tek ▻ large selection from stock ✓ Top brands ✓ available immediately ▻ order online now!Stock Price Forecast. The 2 analysts with 12-month price forecasts for PCSA stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 187.08% from the current stock price of 2.09. how to send mail Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) provides interim analysis from its Phase 1b study of Next Generation Capecitabine (NGC-Cap), showing improved safety and efficacy over capecitabine. Patients received lower doses of NGC-Cap resulting in 5-FU exposure up to 10 times greater than capecitabine, with similar side effect … hawaii maui flights 免费的Processa Pharmaceuticals (PCSA)分析工具，包括分析师评级、目标价预测，帮助您做出明智的投资决策.Company. Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive. Suite 106. Hanover, MD 21076. T: 443.776.3133. F: 443.288.4420‬. The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. yj maxx May 16, 2024 1:36 AM ET Adial Pharmaceuticals, Inc. (ADIL) Stock By: Meghavi Singh, SA News Editor. Adial Pharmaceuticals press release ( NASDAQ: ADIL ): Q1 net …See Processa Pharmaceuticals, Inc. (PCSA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. hubspot sales A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Processa Pharmaceuticals (NASDAQ:PCSA) on Friday priced the public offering of its stock and warrants to raise gross proceeds of up to $7 million.The offering will consist of 1,555,555 shares or ... arabic writing in arabic PCSA Dividend History. The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides ...Stock Analysis provides real-time and historical data, news, charts and analysis for PCSA, a clinical-stage pharmaceutical company focused on developing the next generation of 5 … coop credit union montevideo mn About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Processa Pharmaceuticals, Inc. Common Stock (PCSA) Pre ... milwaukee to vegas Stock Price Forecast. The 2 analysts with 12-month price forecasts for PCSA stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 187.08% from the current stock price of 2.09.HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next... Insider Buying: Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Director Buys 8,000 Shares of Stock Zolmax • 3 months ago. esty store When it comes to building a well-stocked kitchen, having the right tools and essentials is essential. Whether you’re an avid home cook or just starting out in the culinary world, h...Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.PCSA. Press Releases Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering. 19d ago. PCSA. Company Announcements Processa Pharmaceuticals Announces Offering Pricing Details. 20d ago. 8K. PCSA. Company Announcements Processa Pharmaceuticals Secures $7M in Public Offering.